173 related articles for article (PubMed ID: 20216406)
1. Detection of bone marrow metastases of neuroblastoma with immunohistochemical staining of CD56, chromogranin A, and synaptophysin.
Park SJ; Park CJ; Kim S; Jang S; Chi HS; Kim MJ; Im HJ; Seo JJ
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):348-52. PubMed ID: 20216406
[TBL] [Abstract][Full Text] [Related]
2. Improving Detection of Metastatic Neuroblastoma in Bone Marrow Core Biopsies: A Proposed Immunohistochemical Approach.
Parsons LN; Gheorghe G; Yan K; Simpson P; Jarzembowski JA
Pediatr Dev Pathol; 2016; 19(3):230-6. PubMed ID: 26491958
[TBL] [Abstract][Full Text] [Related]
3. Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin.
Krishnan C; Twist CJ; Fu T; Arber DA
Am J Clin Pathol; 2009 Jan; 131(1):49-57. PubMed ID: 19095565
[TBL] [Abstract][Full Text] [Related]
4. Detection of neuroblastoma in the bone marrow: biopsy versus aspiration.
Aronica PA; Pirrotta VT; Yunis EJ; Penchansky L
J Pediatr Hematol Oncol; 1998; 20(4):330-4. PubMed ID: 9703007
[TBL] [Abstract][Full Text] [Related]
5. [Histological and immunohistochemical diagnosis of bone marrow metastases of neuroblastomas].
Boman F; Chastagner P; Floquet J; Sommelet D; Aymard B; Palau R; Kleinclaus I
Bull Cancer; 1991; 78(10):943-51. PubMed ID: 1768940
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of morphological/immunohistochemical versus nuclear medicine imaging modalities in detecting metastatic bone and/or marrow deposits in neuroblastoma patients.
Zaher Ael-S; Zaher AM; Moneer MM; El Gamal BM
J Egypt Natl Canc Inst; 2011 Jun; 23(2):79-88. PubMed ID: 22099965
[TBL] [Abstract][Full Text] [Related]
7. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
Chen JF; Yang C; Sun Y; Cao D
Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
[TBL] [Abstract][Full Text] [Related]
8. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
[TBL] [Abstract][Full Text] [Related]
9. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
Zou Q; Zhang L; Cheng Z; Guo X; Cao D
Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the cell immunophenotype of metastatic and primary foci in stage IV-S neuroblastoma.
Nowicki M; Miśkowiak B
Folia Histochem Cytobiol; 2002; 40(3):297-303. PubMed ID: 12219840
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
[TBL] [Abstract][Full Text] [Related]
12. Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
Krishnan C; Higgins JP; West RB; Natkunam Y; Heerema-McKenney A; Arber DA
Am J Surg Pathol; 2009 Nov; 33(11):1695-704. PubMed ID: 19701075
[TBL] [Abstract][Full Text] [Related]
13. Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry.
Bozzi F; Gambirasio F; Luksch R; Collini P; Brando B; Fossati-Bellani F
Anticancer Res; 2006; 26(5A):3281-7. PubMed ID: 17094441
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
Russell HV; Hicks J; Okcu MF; Nuchtern JG
J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
[TBL] [Abstract][Full Text] [Related]
15. Detection of metastatic neuroblastoma in bone marrow biopsy specimens with an antibody to neuron-specific enolase.
Crary GS; Singleton TP; Neglia JP; Swanson PE; Strickler JG
Mod Pathol; 1992 May; 5(3):308-11. PubMed ID: 1495935
[TBL] [Abstract][Full Text] [Related]
16. Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?
Cheung NK; Heller G; Kushner BH; Liu C; Cheung IY
J Clin Oncol; 1997 Aug; 15(8):2807-17. PubMed ID: 9256123
[TBL] [Abstract][Full Text] [Related]
17. Comparative Analysis of Flow Cytometry and Cytomorphology for Neuroblastoma Cell Detection in Effusion and Bone Marrow Specimens.
Ye W; Wang J; Li W; Shen H
Fetal Pediatr Pathol; 2019 Feb; 38(1):1-7. PubMed ID: 30667298
[TBL] [Abstract][Full Text] [Related]
18. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow.
Hata JL; Correa H; Krishnan C; Esbenshade AJ; Black JO; Chung DH; Mobley BC
Arch Pathol Lab Med; 2015 Apr; 139(4):543-6. PubMed ID: 25822764
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of stage IV neuroblastoma metastatic immunophenotype in the bone marrow: preliminary report.
Nowicki M; Ostalska-Nowicka D; Miskowiak B
J Clin Pathol; 2006 Feb; 59(2):150-2. PubMed ID: 16443729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
